Clinical trial
Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate…
NCT00137657 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00137657 |
|---|---|
| Title | Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance |
| Official title | An Evaluation of the Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on the Development of Antifolate Resistance Among Plasmodium Falciparum, Streptococcus Pneumoniae, and Escherichia Coli |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Kenya Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV, Malaria, Diarrhea, Pneumonia, Opportunistic Infections |
| Intervention type | Drug |
| Interventions | Cotrimoxazole (trimethoprim sulfamethoxazole) |
| Enrollment | 1,478 |
| Start date | Feb 1, 2002 |
| Completion | Nov 1, 2003 |
| First posted | Aug 30, 2005 |
| Last update posted | Dec 13, 2005 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: